Moderate and mild hemophilia A differ from the severe form not only in clinical course and bleeding risk, but also in the risk of developing neutralizing antibodies (inhibitors).
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
